Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease
- Jeffry S. Nyman
- , Alyssa R. Merkel
- , Sasidhar Uppuganti
- , Bijaya Nayak
- , Barbara Rowland
- , Alexander J. Makowski
- , Babatunde O. Oyajobi
- , Julie A. Sterling
Research output: Contribution to journal › Article › peer-review
48
Link opens in a new tab
Scopus
citations